Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 11 to 20 of 5914 Results
July 06, 2026
Vertex to Acquire Crinetics Pharmaceuticals
$10 Billion
July 06, 2026
Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders
$2 Billion
July 03, 2026
David Brown Defence announces acquisition by RENK Group
Undisclosed
July 03, 2026
Lazard acted as financial advisor to TenneT Holding on the sale of a 25.1% stake in TenneT Germany to KfW for approximately €3.3bn plus additional primary equity commitments to fund future equity needs
$47.3 Billion
July 02, 2026
Kestrel has Entered into an Exclusive Option-to-Acquire Agreement with AbbVie
$1.4 Billion
July 01, 2026
Olympus Partners Acquires Network Connex
Undisclosed
June 30, 2026
Ecovyst Announces Agreement to Acquire Calabrian Sulfur Dioxide & Sulfur Derivatives Business
$190 Million
June 30, 2026
Fédération Nationale du Crédit Agricole announces its intention to purchase up to €800m of Crédit Agricole S.A. shares
$935.6 Million
June 30, 2026
Bureau Veritas announces that it has entered exclusive negotiations with Triton Partners regarding the sale of its Oil & Petrochemicals and Coal testing and inspection business.
$536.1 Million
June 30, 2026